Copper therapy with radiation for chest cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a drug called disulfiram (which affects copper in the body) combined with radiation therapy for people with chest cancer that has spread or is advanced. The goal is to see if this combination can help control the cancer better than radiation alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed cancer in the chest area that has spread or is advanced.
- You will be getting radiation therapy as part of your treatment, not just for pain relief.
- You must be at least 18 years old.
- You must be able to care for yourself (ECOG score 0-2).
- Your liver, kidneys, and blood counts must be within acceptable levels.
- You must be willing to avoid all alcohol while taking the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an oral supplement called sodium-copper chlorophyllin can reduce long-term side effects from radiation therapy in women with cervical cancer. It is designed for people whose radiation plan delivers a higher dose to the rectum or bladder than usually recommended.
This trial tests whether taking copper supplements can help people with cirrhosis (scarring of the liver) who have low copper levels or symptoms related to copper deficiency. It aims to see if this can improve their health.
This trial tests a combination of low-dose radiation, chemotherapy, and immunotherapy for people with colorectal cancer that has spread only to the liver. The goal is to see if this approach can shrink tumors and improve outcomes.
This trial tests combining focused radiation (SBRT) with immunotherapy for colorectal cancer that has spread to the liver or lungs. The goal is to see if this combination can shrink tumors and improve control of the cancer.
This trial tests a type of radiation therapy for people with advanced gallbladder cancer that cannot be removed by surgery. It is for those whose cancer has not spread to other parts of the body and has stayed stable or improved after initial chemotherapy.
This trial tests a combination of liver-directed radiation therapy, an immunotherapy drug (which helps your immune system fight cancer), and a drug that blocks blood vessel growth to the tumor. It is for people with advanced liver cancer that cannot be treated with surgery.
Hear when a new Thoracic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.